LifeMD, Inc.
LFMD
$4.27
-$0.40-8.57%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 38.27% | 40.94% | 33.26% | 59.53% | 22.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.27% | 40.94% | 33.26% | 59.53% | 22.93% |
| Cost of Revenue | 4.85% | 10.48% | 9.14% | 31.66% | 1.37% |
| Gross Profit | 43.00% | 45.35% | 36.78% | 64.25% | 26.73% |
| SG&A Expenses | 37.01% | 41.59% | 42.80% | 33.52% | 14.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 29.48% | 51.13% | 39.99% | 3.32% | -12.94% |
| Total Operating Expenses | 34.49% | 39.48% | 39.85% | 34.46% | 12.96% |
| Operating Income | -2.55% | -28.80% | -116.32% | 68.33% | 32.98% |
| Income Before Tax | 0.73% | -16.05% | -93.14% | 75.08% | 26.60% |
| Income Tax Expenses | -- | -- | -- | 18.66% | -- |
| Earnings from Continuing Operations | -3.67% | -16.05% | -93.14% | 72.16% | 26.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 141.20% | 95.41% | 78.90% | -41.56% | -902.75% |
| Net Income | 16.18% | -2.12% | -68.85% | 68.73% | 15.92% |
| EBIT | -2.55% | -28.80% | -116.32% | 68.33% | 32.98% |
| EBITDA | -0.36% | -29.43% | -127.85% | 71.34% | 9.10% |
| EPS Basic | 29.74% | 19.64% | -27.35% | 69.68% | 23.19% |
| Normalized Basic EPS | 41.88% | 24.84% | -37.15% | 62.72% | 16.07% |
| EPS Diluted | 29.74% | 17.61% | -27.35% | 68.94% | 23.19% |
| Normalized Diluted EPS | 41.88% | 24.84% | -37.15% | 62.72% | 16.07% |
| Average Basic Shares Outstanding | 21.90% | 26.83% | 23.87% | 16.96% | 11.43% |
| Average Diluted Shares Outstanding | 21.90% | 26.83% | 23.87% | 16.96% | 11.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.19% | 0.02% | 0.41% | -2.20% | -0.19% |
